flamesong Major Poster
Joined: 27 Jul 2005 Posts: 1305 Location: okulo news
|
Posted: Tue Jun 26, 2007 3:28 pm Post subject: VeriChip News Release - Madeleine McCann - PRS |
|
|
It was suggested by many that the Madeleine McCann case would trigger an 'interest' in RFID implants. Well, they don't go so far as mentioning her name but this press release from VeriChip is expediently timed:
June 25 2007
VeriChip Corporation Launches New Customer Support Initiative for Infant Protection
By Your Side program sets new standard in support
VeriChip Corporation (Nasdaq: CHIP), a provider of RFID systems for healthcare and patient-related needs, announced today its wholly owned subsidiary, Xmark Corporation, launched the By Your Side™ program for its infant protection products at the Association of Women’s Health, Obstetric and Neonatal Nurses (AWHONN) Convention in Orlando, FL.
The By Your Side program provides Xmark’s infant protection customers with an unmatched level of support to ensure success with their Halo or Hugs infant protection system. It is Xmark’s commitment that every customer will be successful with infant protection.
The program has five main components: Implementation Support, Clinical Education, Parent Education, Public Relations and Continuing Clinical Support. Created with substantial input from current customers, industry experts and Xmark’s clinical education staff, the program is designed to provide customers with close and continuing support throughout the product life cycle, from initial purchase to implementation to ongoing use.
Speaking from the AWHONN Convention, Daniel A. Gunther, President and CEO of Xmark, said, “Xmark’s dominance of the infant protection market is the result of listening closely to our customers and giving them products that work in their environment. The By Your Side program is the next step in our efforts to truly partner with our customers and provide the best possible infant protection. It’s a commitment for the long term that none of our competitors have made.”
The AWHONN Convention is the nation’s largest gathering of nurses, nurse practitioners and nurse executives in the field of maternal/child care. By launching the By Your Side program at the show, Xmark is reaching directly more than 2000 decision makers who drive the purchase of infant protection systems.
Xmark’s Halo system and Hugs system are part of its industry-leading portfolio of infant protection products. One out of every three infant protection systems in the United States is an Xmark product.
For more information on Xmark’s products, please contact 1-866-55–XMARK or email sales@xmark.com. Additional information can be found online at www.xmark.com.
About Xmark
Based in Ottawa, Ontario, Xmark is a wholly owned subsidiary of VeriChip Corporation. For over 25 years, Xmark Corporation has provided Radio Frequency Identification (RFID) solutions to identify, locate, and protect people and assets in healthcare environments. Its market-leading infant protection, wander prevention, personal duress, and asset tracking applications are trusted by over 5,000 healthcare institutions worldwide to keep individuals safe.
Xmark products are installed and serviced through an international network of authorized dealers, backed by a dedicated technical services department at Xmark. All aspects of Xmark’s business are certified to the ISO 9001 quality standard.
About VeriChip
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. The Company recently began marketing its VeriMed(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Solutions Inc. (Nasdaq: ADSX), which also owns a majority position in Digital Angel Corporation (Amex: DOC). For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. |
|